Detalhe da pesquisa
1.
Profiling the role of m6A effectors in the regulation of pluripotent reprogramming.
Hum Genomics
; 18(1): 33, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566168
2.
Development and validation of an inflammatory biomarkers model to predict gastric cancer prognosis: a multi-center cohort study in China.
BMC Cancer
; 24(1): 711, 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38858653
3.
LncRNA Osilr9 coordinates promoter DNA demethylation and the intrachromosomal loop structure required for maintaining stem cell pluripotency.
Mol Ther
; 31(6): 1791-1806, 2023 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523163
4.
Manufacturing CAR-NK against tumors: Who is the ideal supplier?
Chin J Cancer Res
; 36(1): 1-16, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38455373
5.
Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study.
Breast Cancer Res Treat
; 197(3): 489-501, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459284
6.
BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists.
J Transl Med
; 21(1): 108, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765389
7.
Malnutrition diagnosed by GLIM criteria better predicts long-term outcomes for patients with non-Hodgkin's lymphoma: A prospective multicenter cohort study.
Hematol Oncol
; 41(3): 371-379, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36416610
8.
Association of Phase Angle with Overall Survival in Patients with Cancer: A Prospective Multicenter Cohort Study.
Nutr Cancer
; 75(3): 890-900, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632984
9.
Cellular immunotherapy combined with platinum-based chemotherapy prolongs survival for non-small cell lung cancer patients.
Neoplasma
; 70(2): 251-259, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005956
10.
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial.
Lancet Oncol
; 23(2): 220-233, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038432
11.
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial.
Lancet Oncol
; 23(9): 1167-1179, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35908558
12.
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial.
Lancet Oncol
; 23(2): 209-219, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038429
13.
Profiling the long noncoding RNA interaction network in the regulatory elements of target genes by chromatin in situ reverse transcription sequencing.
Genome Res
; 29(9): 1521-1532, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31315906
14.
High Visceral Fat in Female Breast Cancer Patients Correlates with the Risk of Progression after Adjuvant Chemotherapy.
Nutr Cancer
; 74(6): 2038-2048, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35068282
15.
Fat mass assessment using the triceps skinfold thickness enhances the prognostic value of the Global Leadership Initiative on Malnutrition criteria in patients with lung cancer.
Br J Nutr
; 127(10): 1506-1516, 2022 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34218831
16.
Oplr16 serves as a novel chromatin factor to control stem cell fate by modulating pluripotency-specific chromosomal looping and TET2-mediated DNA demethylation.
Nucleic Acids Res
; 48(7): 3935-3948, 2020 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32055844
17.
Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma.
Hepatobiliary Pancreat Dis Int
; 21(1): 10-24, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538570
18.
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.
Lancet Oncol
; 22(7): 977-990, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34143971
19.
The correlation between skeletal muscle index of the L3 vertebral body and malnutrition in patients with advanced lung cancer.
BMC Cancer
; 21(1): 1148, 2021 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34702196
20.
Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
BMC Cancer
; 21(1): 56, 2021 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33435909